Biblio

33557 resultats trouvés
R
Jarrige F.  2014.  The Rural War: Captain Swing and the Politics of Protest. SOCIAL HISTORY. 39:119-121.
Fournel I, Cottet V, Binquet C, Jooste V, Faivre J, Bouvier A-M, Bonithon-Kopp C.  2014.  Rural-urban differences in the long-term risk of colorectal cancer after adenoma removal: A population-based study. DIGESTIVE AND LIVER DISEASE. 46:376-382.
Modesto KArrais Gui, de Oliveira PFerreira A, Fonseca HGoncalves, Azevedo KPorto, Guzzoni V, Bottaro M, Babault N, Durigan JLuiz Quagl.  2020.  Russian and Low-Frequency Currents Induced Similar Neuromuscular Adaptations in Soccer Players: A Randomized Controlled Trial. JOURNAL OF SPORT REHABILITATION. 29:594-601.
Bourin J-C, Lee E-Y.  2019.  On the Russo-Dye Theorem for positive linear maps. LINEAR ALGEBRA AND ITS APPLICATIONS. 571:92-102.
Harvey PD, Tasan S, Gros CP, Devillers CH, Richard P, Le Gendre P, Bodio E.  2015.  Ruthenium and Osmium Complexes of Phosphine-Porphyrin Derivatives as Potential Bimetallic Theranostics: Photophysical Studies. ORGANOMETALLICS. 34:1218-1227.
Abel AS, Averin AD, Cheprakov AV, Beletskaya IP, Meyer M, Bessmertnykh-Lemeune A.  2022.  Ruthenium(II) Complexes with (3-Polyamino)phenanthrolines: Synthesis and Application in Sensing of Cu(II) Ions. CHEMOSENSORS. 10:79.
Simonet M, Berceanu A, Daguindau E, Desbrosses Y, Deconinck E, Larosa F.  2019.  Ruxolitinib: An effective JAK1/2 inhibitor in salvage therapy of refractory chronic GVHD. BONE MARROW TRANSPLANTATION. 54:320.
Simonet M, Berceanu A, Daguindau E, Desbrosses Y, Deconinck E, Larosa F.  2019.  Ruxolitinib: An effective JAK1/2 inhibitor in salvage therapy of refractory chronic GVHD. BONE MARROW TRANSPLANTATION. 54:320.
Girard N, Pichon E, Thomas P-A, Lena H, Dansin E, Massard G, Zalcman G, Mazieres J, Thiberville L, Westeel V et al..  2014.  RYTHMIC: INSIGHTS IN THE MANAGEMENT OF ADVANCED THYMIC EPITHELIAL TUMORS. JOURNAL OF THORACIC ONCOLOGY. 9:S223-S224.
S
Salon C, Bataille M-P, Gallardo K, Jeudy C, Santoni A-L, Trouverie J, Voisin A-S, Avice J-C.  2014.  S-34 and N-15 Labelling to Model S and N Flux in Plants and Determine the Different Components of N and S Use Efficiency. PLANT METABOLIC FLUX ANALYSIS: METHODS AND PROTOCOLS. 1090:335-346.
Noiret N, Carvalho N, Laurent E, Chopard G, Binetruy M, Nicolier M, Monnin J, Magnin E, Vandel P.  2018.  Saccadic Eye Movements and Attentional Control in Alzheimer's Disease. ARCHIVES OF CLINICAL NEUROPSYCHOLOGY. 33:1-13.
Carvalho N, Noiret N, Vandel P, Monnin J, Chopard G, Laurent E.  2014.  Saccadic Eye Movements in Depressed Elderly Patients. PLOS ONE. 9:e105355.
Noiret N, Vigneron B, Diogo M, Vandel P, Laurent E.  2017.  Saccadic eye movements: what do they tell us about aging cognition? AGING NEUROPSYCHOLOGY AND COGNITION. 24:575-599.
Boukricha S., Ghoumid K., Mekaoui S., Ar-Reyouchi E., Bourouina H., Yahiaoui R..  2020.  SAC-OCDMA system performance using narrowband Bragg filter encoders and decoders. SN APPLIED SCIENCES. 2:1002.
Bakrim N., Chabannes E., Detree P., Balssa L., Wagner L., Kleinclauss F..  2022.  Sacral neuromodulation as treatment of non-neurological vesical emptying disorders. PROGRES EN UROLOGIE. 32:14-22.
Pialat J.-B, Di Marco L., Feydy A., Peyron C., Porta B., Himpens P.-H, Ltaief-Boudrigua A., Aubry S..  2016.  Sacroiliac joints imaging in axial spondyloarthritis. DIAGNOSTIC AND INTERVENTIONAL IMAGING. 97:697-708.
Razanamahery J, Dresco F, Emile JFrancois, Verhoeven F, Algros MPaiule, Lodovichetti J, Humbert S, Bouiller K, Magy-Bertrand N.  2020.  Sacroiliitis in a patient with Rosai-Dorfman disease: new bone location or overlap with axial spondylarthritis? RHEUMATOLOGY. 59:2168-2170.
Fouquet G., Pegourie B., Macro M., Petillon M.O, Karlin L., Caillot D., Roussel M., Arnulf B., Mathiot C., Marit G. et al..  2016.  Safe and prolonged survival with long-term exposure to pomalidomide in relapsed/refractory myeloma. ANNALS OF ONCOLOGY. 27:902-907.
Awad N, Bouna BAl, Couchot J-F, Philippe L.  2019.  Safe disassociation of set-valued datasets. JOURNAL OF INTELLIGENT INFORMATION SYSTEMS. 53:547-562.
Pierot L, Spelle L, Berge J, Januel A-C, Herbreteau D, Aggour M, Piotin M, Biondi A, Barreau X, Mounayer C et al..  2019.  SAFE study (Safety and efficacy Analysis of FRED Embolic device in aneurysm treatment): 1-year clinical and anatomical results. JOURNAL OF NEUROINTERVENTIONAL SURGERY. 11:184-189.
Di Caterino F., Primikiris P., Vitale G., Charbonnier G., Biondi A..  2021.  Safeguard pressure assisted device for local femoral hemostasis in neuroendovascular procedures: A single center study of 879 patients. JOURNAL OF NEURORADIOLOGY. 48:385-390.
Gligorov J., Ataseven B., Verrill M., De Laurentiis M., Jung K.H, Azim H.A, Al-Sakaff N., Lauer S., Shing M., Pivot X..  2016.  SafeHer Phase III study primary analysis: Safety of subcutaneous trastuzumab plus chemotherapy for early breast cancer. EUROPEAN JOURNAL OF CANCER. 57:S89-S90.
Moffa AH, Brunoni AR, Fregni F, Palm U, Padberg F, Blumberger DM, Daskalakis ZJ, Bennabi D, Haffen E, Alonzo A et al..  2017.  Safety and acceptability of transcranial direct current stimulation for the acute treatment of major depressive episodes: Analysis of individual patient data. JOURNAL OF AFFECTIVE DISORDERS. 221:1-5.
Palanca-Wessels MCorinna A, Czuczman M, Salles G, Assouline S, Sehn LH, Flinn I, Patel MR, Sangha R, Hagenbeek A, Advani R et al..  2015.  Safety and activity of the anti-CD79B antibody-drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study. LANCET ONCOLOGY. 16:704-715.
Basso V, Orry D, Fraisse J, Vincent J, Hennequin A, Bengrine L, Ghiringhelli F.  2019.  Safety and efficacy of a docetaxel-5FU-oxaliplatin regimen with or without trastuzumab in neoadjuvant treatment of localized gastric or gastroesophageal junction cancer: A retrospective study. WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY. 11:634-641.

Pages